Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20179255 | 0.86 | LMNA (0.49) | HPGDMAPTGAALMNAALDH1A1 | |
| SCHEMBL18656997 | 0.83 | GAA (0.54) | HPGDMAPTRAB9AGAALMNA | |
| SCHEMBL18627999 | 0.83 | GAA (0.54) | HPGDMAPTRAB9AGAALMNA | |
| SCHEMBL18628000 | 0.83 | GAA (0.54) | HPGDMAPTRAB9AGAALMNA | |
| SCHEMBL18656991 | 0.82 | LMNA (0.45) | HPGDMAPTGAALMNAALDH1A1 | |
| SCHEMBL18656977 | 0.79 | ALDH1A1 (0.46) | HPGDMAPTRAB9AGAALMNA | |
| SCHEMBL13679391 | 0.79 | RAB9A (0.60) | HPGDMAPTRAB9AGAAALDH1A1 | |
| SCHEMBL9861909 | 0.78 | MAPT (0.64) | HPGDMAPTRAB9AGAALMNA | |
| SCHEMBL12516805 | 0.78 | ALDH1A1 (0.69) | HPGDMAPTGAALMNAALDH1A1 | |
| SCHEMBL6033676 | 0.78 | LMNA (0.63) | HPGDMAPTGAALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190367652-A1 | ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE | EVONIK TECHNOCHEMIE GMBH (DE) | 2019-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190367652-A1 | ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE | ITGB3, C9, CBR3 | HPGD 1007/4885MAPT 647/4885RAB9A 4519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.